Infinity Pharmaceuticals, Inc . (NASDAQ: INFI) announced today the appointment of Richard Gaynor, M.D. to its Board of Directors, effective March 16, 2020. “We are thrilled to have Dr. Gaynor join the board as we advance IPI-549 to important data readouts,” said Adelene Perkins, Chief Executive Officer and Chair of Infinity Pharmaceuticals. “Richard’s tremendous expertise, first as a practicing academic oncologis
March 17, 2020
· 5 min read